Regulatory Affairs

In April 2025, Chengyi Pharma secured environmental approval for its USD 0.28 million vitamin K1 API project in China,...

Lianhuan Pharmaceutical announced that its Mecobalamin Injection passed China's generic drug consistency evaluation, boosting its position in the vitamin...

Jiankun Pharmaceutical secured environmental approval for its USD 10.73 million project to produce VD3 oil, powder, and crystals, strengthening...

Yize Pharmaceutical received environmental approval for its 1,000 t/a vitamin B6 project in Inner Mongolia, strengthening its role in...

On early April, 2025, Guangxi Minglei Weisheng Pharmaceutical Co., Ltd. gained approval for China's first newborn-specific vitamin K1 oral...

April 2025 witnessed vital expansions, regulatory approvals, and strategic partnerships in China's vitamin industry, with U.S. tariffs sparing key...

China’s SAMR has issued new regulations on infant formula milk powder raw materials, while Hohhot and Fuping’s dairy sectors...

China's State Council approves revised plant variety protection regulations, aiming to boost seed industry innovation and enforce stronger intellectual...

Zhongjiang Seed Industry faces a court hearing after failing to repay loans exceeding USD 2 million, but claims no...

The U.S. tariff exemption for dietary ingredients like vitamins and amino acids is expected to ease market pressures and...